European pharmaceutical company Besins Healthcare will invest about 500 million rubles in the construction of a pharmaceutical factory in the Yaroslavl region.
Besins Healthcare SA will build a new drug manufacturing plant in Yaroslavl Region. The new facility will produce Utrogestan which is included in the Russia's Essential Drugs List. Project investment will account for RUB 500 mln, the launch of commercial production is scheduled for 2019.
Israeli Teva Pharmaceutical Industries, one of the world’s largest drug producers, will double the drug production at its Yaroslavl plant to 500 mln pills in 2016.
Construction of 450 MW Huadian-Teninskaya CCPP has been completed in Yaroslavl Region Pre-commissioning works have been started at the facility that is expected to reduce the region’s power shortages
Takeda has launched its integrated production of Actovegin in the form of sterile injection solution at its Yaroslavl plant. Thus all forms of the drug (pills and injections solutions) are now produced in Russia.
Russian Grids signed an agreement on strategic partnership with Prismian RUS, the Russian representative of Prysmian Group, producer of cabling and wiring products. The Agreement provides for the localization of cable production on the Rybinskelectrokabel plant in Rybinsk as well as development and implementation of innovative technological solutions for the electric grid complex in Russia.